Upperton adds Mass Spectroscopy to its analytical capabilities
Upperton Pharma Solutions has now completed the installation and commissioning of its Agilent 1100 series LC/MSD (Liquid Chromatography mass selective detector) with ESI (Electrospray ionisation). The new capability will allow Upperton to offer clients molecular mass analysis, useful for assessing purity and detecting API decomposition or modification during formulation processing.
Contact Upperton and discuss how we can use this technique to characterise your API before, during and after formulation and dosage form development
Upperton will be attending the 9th International GI-Targeting Seminar hosted by Evonik in Darmstadt, Germany
This 2-days seminar takes place between June 6-7, 2018 and offers attendees hands-on practical sessions in the Evonik laboratories.
Upperton Pharma Solutions we will be attending the APS Regulatory Essentials Conference in Loughborough 22nd-23rd May. If you are there, talk to us about your GMP Spray drying requirements
Upperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP manufacturing capabilities for early phase clinical trials.
The 15,000 square foot facility will house all of the company’s R&D team, as well as its fast-growing Quality Assurance and Manufacturing departments. Within the building is a clean room suite suitable for cGMP manufacture, and a pilot plant for non-GMP intermediate scale manufacturing. Upperton plans to have an MHRA licence for clinical trials manufacturing by Q3 of 2018.
The relocation and expansion will allow the company to offer a full integrated pharmaceutical development service, from early feasibility studies through to cGMP manufacture to support clinical trials. The extended range of capabilities includes:
cGMP manufacturing for clinical trials, release testing and QP release
Range of additional powder handling and filling capabilities
Enhanced dosage form development service
Expanded analytical service
In the coming weeks we will be sharing more news about our move and the new services we will be offering our customers.
Upperton will be presenting at Spray Drying and Atomisation of Formulations the University of Leeds 20-22nd March 2018 at Faculty of Engineering, Leeds University. The course is the UK’s leading conference dedicated to the science and engineering of spray drying
The talk entitled “Spray Drying of Pharmaceuticals” will be given by Dr Andrew Naylor on the 21st March 2018
Upperton Limited will be attending the Making Pharmaceuticals Exhibition & Conference at the Ricoh Arena, Coventry from 25-26 April 2017. We would be delighted to hear from any delegates who are interested in learning more about our services and capabilities. Find out more from the conference website
A new 4M8-Trix ProCepT spray dryer has been delivered and is now being commissioned at Upperton. It brings the number of spray dryers that we have in our laboratory and pilot plant to eleven.
Nottingham, UK – 18th November, 2016 —Upperton is pleased to announce that it has acquired a Quantos MicroDosing unit that can be used to precisely fill a range of dosage forms including capsules, and devices for inhaled and nasal drug delivery. The new Quantos system is capable of dosing to an accuracy of ± 0.5mg, independent of substance characteristics, operator or environmental conditions. The system learns the characteristics of a product, with an RFID chip present in the dosing head storing all the key information on the substance used, including batch number and powder characteristics. Actual fill weights of each individual capsule or device are captured electronically and can be printed if required.
With over 20 years of experience we have successfully spray dried, formulated and characterised a vast range of pharmaceutical and biotechnology products for companies across the globe.
